Cargando…
Molecular xenomonitoring for post-validation surveillance of lymphatic filariasis in Togo: no evidence for active transmission
BACKGROUND: Lymphatic filariasis (LF) is a mosquito-borne filarial disease targeted for elimination by the year 2020. The Republic of Togo undertook mass treatment of entire endemic communities from 2000 to 2009 to eliminate the transmission of the disease and is currently the first sub-Saharan Afri...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781303/ https://www.ncbi.nlm.nih.gov/pubmed/29361964 http://dx.doi.org/10.1186/s13071-017-2611-9 |
_version_ | 1783294924476645376 |
---|---|
author | Dorkenoo, Monique A. de Souza, Dziedzom K. Apetogbo, Yao Oboussoumi, Komla Yehadji, Degninou Tchalim, Mawèke Etassoli, Santrao Koudou, Benjamin Ketoh, Guillaume K. Sodahlon, Yao Bockarie, Moses J. Boakye, Daniel A. |
author_facet | Dorkenoo, Monique A. de Souza, Dziedzom K. Apetogbo, Yao Oboussoumi, Komla Yehadji, Degninou Tchalim, Mawèke Etassoli, Santrao Koudou, Benjamin Ketoh, Guillaume K. Sodahlon, Yao Bockarie, Moses J. Boakye, Daniel A. |
author_sort | Dorkenoo, Monique A. |
collection | PubMed |
description | BACKGROUND: Lymphatic filariasis (LF) is a mosquito-borne filarial disease targeted for elimination by the year 2020. The Republic of Togo undertook mass treatment of entire endemic communities from 2000 to 2009 to eliminate the transmission of the disease and is currently the first sub-Saharan African country to be validated by WHO for the elimination of LF as a public health problem. However, post-validation surveillance activities are required to ensure the gains achieved are sustained. This survey assessed the mosquito vectors of the disease and determined the presence of infection in these vectors, testing the hypothesis that transmission has already been interrupted in Togo. METHOD: Mosquitoes were collected from 37 villages located in three districts in one of four evaluation units in the country. In each district, 30 villages were selected based on probability proportionate to size; eight villages (including one of the 30 villages already selected) where microfilaremia-positive cases had been identified during post-treatment surveillance activities were intentionally sampled. Mosquitoes were collected using pyrethrum spray collections (PSC) in households randomly selected in all villages for five months. In the purposefully selected communities, mosquitoes were also collected using human landing collections (HLC) and exit traps (ET). Collected mosquitoes were identified morphologically, and the identification of Wuchereria bancrofti DNA in the mosquitoes was based on the pool screening method, using the LAMP assay. RESULTS: A total of 15,539 mosquitoes were collected during the study. Anopheles gambiae (72.6%) was the predominant LF vector collected using PSC. Pool screen analysis of 9191 An. gambiae in 629 pools revealed no mosquitoes infected with W. bancrofti (0%; CI: 0–0.021). CONCLUSIONS: These results confirm the findings of epidemiological transmission assessment surveys conducted in 2012 and 2015, which demonstrated the absence of LF transmission in Togo. The challenges of implementing molecular xenomonitoring are further discussed. |
format | Online Article Text |
id | pubmed-5781303 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-57813032018-02-06 Molecular xenomonitoring for post-validation surveillance of lymphatic filariasis in Togo: no evidence for active transmission Dorkenoo, Monique A. de Souza, Dziedzom K. Apetogbo, Yao Oboussoumi, Komla Yehadji, Degninou Tchalim, Mawèke Etassoli, Santrao Koudou, Benjamin Ketoh, Guillaume K. Sodahlon, Yao Bockarie, Moses J. Boakye, Daniel A. Parasit Vectors Research BACKGROUND: Lymphatic filariasis (LF) is a mosquito-borne filarial disease targeted for elimination by the year 2020. The Republic of Togo undertook mass treatment of entire endemic communities from 2000 to 2009 to eliminate the transmission of the disease and is currently the first sub-Saharan African country to be validated by WHO for the elimination of LF as a public health problem. However, post-validation surveillance activities are required to ensure the gains achieved are sustained. This survey assessed the mosquito vectors of the disease and determined the presence of infection in these vectors, testing the hypothesis that transmission has already been interrupted in Togo. METHOD: Mosquitoes were collected from 37 villages located in three districts in one of four evaluation units in the country. In each district, 30 villages were selected based on probability proportionate to size; eight villages (including one of the 30 villages already selected) where microfilaremia-positive cases had been identified during post-treatment surveillance activities were intentionally sampled. Mosquitoes were collected using pyrethrum spray collections (PSC) in households randomly selected in all villages for five months. In the purposefully selected communities, mosquitoes were also collected using human landing collections (HLC) and exit traps (ET). Collected mosquitoes were identified morphologically, and the identification of Wuchereria bancrofti DNA in the mosquitoes was based on the pool screening method, using the LAMP assay. RESULTS: A total of 15,539 mosquitoes were collected during the study. Anopheles gambiae (72.6%) was the predominant LF vector collected using PSC. Pool screen analysis of 9191 An. gambiae in 629 pools revealed no mosquitoes infected with W. bancrofti (0%; CI: 0–0.021). CONCLUSIONS: These results confirm the findings of epidemiological transmission assessment surveys conducted in 2012 and 2015, which demonstrated the absence of LF transmission in Togo. The challenges of implementing molecular xenomonitoring are further discussed. BioMed Central 2018-01-23 /pmc/articles/PMC5781303/ /pubmed/29361964 http://dx.doi.org/10.1186/s13071-017-2611-9 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Dorkenoo, Monique A. de Souza, Dziedzom K. Apetogbo, Yao Oboussoumi, Komla Yehadji, Degninou Tchalim, Mawèke Etassoli, Santrao Koudou, Benjamin Ketoh, Guillaume K. Sodahlon, Yao Bockarie, Moses J. Boakye, Daniel A. Molecular xenomonitoring for post-validation surveillance of lymphatic filariasis in Togo: no evidence for active transmission |
title | Molecular xenomonitoring for post-validation surveillance of lymphatic filariasis in Togo: no evidence for active transmission |
title_full | Molecular xenomonitoring for post-validation surveillance of lymphatic filariasis in Togo: no evidence for active transmission |
title_fullStr | Molecular xenomonitoring for post-validation surveillance of lymphatic filariasis in Togo: no evidence for active transmission |
title_full_unstemmed | Molecular xenomonitoring for post-validation surveillance of lymphatic filariasis in Togo: no evidence for active transmission |
title_short | Molecular xenomonitoring for post-validation surveillance of lymphatic filariasis in Togo: no evidence for active transmission |
title_sort | molecular xenomonitoring for post-validation surveillance of lymphatic filariasis in togo: no evidence for active transmission |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781303/ https://www.ncbi.nlm.nih.gov/pubmed/29361964 http://dx.doi.org/10.1186/s13071-017-2611-9 |
work_keys_str_mv | AT dorkenoomoniquea molecularxenomonitoringforpostvalidationsurveillanceoflymphaticfilariasisintogonoevidenceforactivetransmission AT desouzadziedzomk molecularxenomonitoringforpostvalidationsurveillanceoflymphaticfilariasisintogonoevidenceforactivetransmission AT apetogboyao molecularxenomonitoringforpostvalidationsurveillanceoflymphaticfilariasisintogonoevidenceforactivetransmission AT oboussoumikomla molecularxenomonitoringforpostvalidationsurveillanceoflymphaticfilariasisintogonoevidenceforactivetransmission AT yehadjidegninou molecularxenomonitoringforpostvalidationsurveillanceoflymphaticfilariasisintogonoevidenceforactivetransmission AT tchalimmaweke molecularxenomonitoringforpostvalidationsurveillanceoflymphaticfilariasisintogonoevidenceforactivetransmission AT etassolisantrao molecularxenomonitoringforpostvalidationsurveillanceoflymphaticfilariasisintogonoevidenceforactivetransmission AT koudoubenjamin molecularxenomonitoringforpostvalidationsurveillanceoflymphaticfilariasisintogonoevidenceforactivetransmission AT ketohguillaumek molecularxenomonitoringforpostvalidationsurveillanceoflymphaticfilariasisintogonoevidenceforactivetransmission AT sodahlonyao molecularxenomonitoringforpostvalidationsurveillanceoflymphaticfilariasisintogonoevidenceforactivetransmission AT bockariemosesj molecularxenomonitoringforpostvalidationsurveillanceoflymphaticfilariasisintogonoevidenceforactivetransmission AT boakyedaniela molecularxenomonitoringforpostvalidationsurveillanceoflymphaticfilariasisintogonoevidenceforactivetransmission |